Colleen L. Forster

7.0k citations

56 papers · 4.3k indexed · 2 hit papers · h-index 27

Physiology top 0.5%
Molecular Biology top 5%
Cellular and Molecular Neuroscience top 1%
Neurology top 0.5%
Pharmacology top 1%

Co-authors: Karen H. Ashe Costantino Iadecola Karen S. SantaCruz Linda Kotilinek Jennifer Paulson Eileen McGowan Jada Lewis Mei Yue
Topics: Alzheimer's disease research and treatments (12 papers)Neuroinflammation and Neurodegeneration Mechanisms (5 papers)Immunotherapy and Immune Responses (5 papers)
Cited by: Neurology Physiology Cellular and Molecular Neuroscience
Journals: Science Proceedings of the National Academy of Sciences Nature Communications
Partner nations: United States Canada Sweden

In The Last Decade

Colleen L. Forster

54 papers receiving 4.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function

2005 1.5k citations Karen S. SantaCruz, Jada Lewis et al. profile →
Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L)

2005 529 citations Martin Ramsden, Linda Kotilinek et al. Journal of Neuroscience profile →

Peers

Countries citing papers authored by Colleen L. Forster

Since Specialization

Citations

This map shows the geographic impact of Colleen L. Forster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colleen L. Forster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colleen L. Forster more than expected).

Fields of papers citing papers by Colleen L. Forster

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colleen L. Forster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colleen L. Forster. The network helps show where Colleen L. Forster may publish in the future.

Co-authorship network of co-authors of Colleen L. Forster

This figure shows the co-authorship network connecting the top 25 collaborators of Colleen L. Forster. A scholar is included among the top collaborators of Colleen L. Forster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colleen L. Forster. Colleen L. Forster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Chondroitin sulfate proteoglycan 4 increases invasion of recessive dystrophic epidermolysis bullosa-associated cutaneous squamous cell carcinoma by modifying transforming growth factor-β signalling 2024 ·British Journal of Dermatology ·(unknown),Jianbo Yang,Matt A. Price,Colleen L. Forster,Megan Riddle,Christen L. Ebens,Frank W. Albert,Alessio Giubellino,James B. McCarthy,Jakub Tolar	1
2	Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma 2023 ·Veterinary Sciences ·Karen Koo,(unknown),Aaron Rendahl,Kyu Young Song,Colleen L. Forster,(unknown),Antonella Borgatti,Alessio Giubellino	0
3	MYO5A::FGFR1represents a novel fusion event in pediatric low-grade glioma 2023 ·Neuro-Oncology Advances ·(unknown),(unknown),(unknown),Colleen L. Forster,Carolina Sandoval-Garcia,Daniel Guillaume,(unknown),Andrew C. Nelson,Can Özütemiz,Liam Chen,Christopher L. Moertel	1
4	Blocking Site-Specific Cleavage of Human Tau Delays Progression of Disease-Related Phenotypes in Genetically Matched Tau-Transgenic Mice Modeling Frontotemporal Dementia 2022 ·Journal of Neuroscience ·(unknown),Lisa J. Kemper,Chris Hlynialuk,(unknown),(unknown),(unknown),Colleen L. Forster,Karen H. Ashe,Peng Liu	5
5	Genomically Complex Human Angiosarcoma and Canine Hemangiosarcoma Establish Convergent Angiogenic Transcriptional Programs Driven by Novel Gene Fusions 2021 ·Molecular Cancer Research ·Jong Hyuk Kim,Kate Megquier,Rachael Thomas,Aaron L. Sarver,Jung Min Song,(unknown),(unknown),(unknown),Michael A. Linden,Paari Murugan,(unknown),Colleen L. Forster,Ingegerd Elvers,Ross Swofford,Jason Turner-Maier,Elinor K. Karlsson,Matthew Breen,Kerstin Lindblad‐Toh,Jaime F. Modiano	16
6	Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis 2019 ·JCI Insight ·Jeremy Herrera,Colleen L. Forster,Thomas Pengo,Ángeles Montero,Joe Swift,Martin A. Schwartz,Craig A. Henke,Peter B. Bitterman	61
7	Factors other than hTau overexpression that contribute to tauopathy-like phenotype in rTg4510 mice 2019 ·Nature Communications ·(unknown),Kellie Benzow,Colleen L. Forster,Lisa J. Kemper,Chris Hlynialuk,Eva Furrow,Karen H. Ashe,Michael D. Koob	118
8	Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid 2018 ·Modern Pathology ·Khalid Amin,Usman Yaqoob,(unknown),Byron P. Vaughn,Alexander Khoruts,(unknown),Todd E. DeFor,Colleen L. Forster,Carolyn Meyer,(unknown),Daniel J. Weisdorf,Armin Rashidi,Margaret L. MacMillan,Bruce R. Blazar,Angela Panoskaltsis‐Mortari,Shernan G. Holtan	12
9	Dicer1 Deficiency in the Idiopathic Pulmonary Fibrosis Fibroblastic Focus Promotes Fibrosis by Suppressing MicroRNA Biogenesis 2018 ·American Journal of Respiratory and Critical Care Medicine ·Jeremy Herrera,Daniel Beisang,Mark S. Peterson,Colleen L. Forster,Adam Gilbertsen,Alexey O. Benyumov,Karen Smith,(unknown),Victor H. Barocas,(unknown),(unknown),Lin Zhang,Craig A. Henke,Peter B. Bitterman	37
10	Safe and Effective Sarcoma Therapy through Bispecific Targeting of EGFR and uPAR 2017 ·Molecular Cancer Therapeutics ·Antonella Borgatti,Joseph S. Koopmeiners,Aaron L. Sarver,(unknown),(unknown),D.A. Todhunter,Anthony E. Rizzardi,Jonathan C. Henriksen,Stephen C. Schmechel,Colleen L. Forster,Jong Hyuk Kim,Jerry Froelich,(unknown),Michael S. Henson,Matthew Breen,Kerstin Lindblad‐Toh,(unknown),(unknown),Jaime F. Modiano,Daniel A. Vallera	33
11	Soluble Conformers of Aβ and Tau Alter Selective Proteins Governing Axonal Transport 2016 ·Journal of Neuroscience ·Mathew A. Sherman,(unknown),Fatou Amar,Megan Larson,Colleen L. Forster,Adriano Aguzzi,David A. Bennett,Martin Ramsden,Sylvain Lesné	43
12	Rb1 and Pten Co-Deletion in Osteoblast Precursor Cells Causes Rapid Lipoma Formation in Mice 2015 ·PLoS ONE ·(unknown),(unknown),Huarui Lu,Colleen L. Forster,(unknown),Timothy C. Hallstrom	14
13	Characterization of a Novel Mouse Model of Alzheimer’s Disease—Amyloid Pathology and Unique β-Amyloid Oligomer Profile 2015 ·PLoS ONE ·Peng Liu,Jennifer Paulson,Colleen L. Forster,Samantha L. Shapiro,Karen H. Ashe,Kathleen R. Zahs	23
14	Mesenchymal stromal cells inhibit murine syngeneic anti-tumor immune responses by attenuating inflammation and reorganizing the tumor microenvironment 2015 ·Cancer Immunology Immunotherapy ·Jaime F. Modiano,(unknown),Ron McElmurry,(unknown),Colleen L. Forster,(unknown),Jerome Schaack,Donald Bellgrau,Timothy D. O’Brien,Jakub Tolar	6
15	Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance 2013 ·Cancer Discovery ·Adrienne L. Watson,Eric P. Rahrmann,Branden S. Moriarity,Kwangmin Choi,Caitlin B. Conboy,(unknown),(unknown),(unknown),(unknown),Vincent W. Keng,Anthony E. Rizzardi,Colleen L. Forster,Margaret H. Collins,Aaron L. Sarver,Margaret R. Wallace,Stephen C. Schmechel,Nancy Ratner,David A. Largaespada	76
16	Pre-conditioning cryosurgery: Cellular and molecular mechanisms and dynamics of TNF-α enhanced cryotherapy in an in vivo prostate cancer model system 2010 ·Cryobiology ·Jing Jiang,Raghav Goel,Stephen C. Schmechel,Gregory M. Vercellotti,Colleen L. Forster,John C. Bischof	31
17	De novo Induction of Genetically Engineered Brain Tumors in Mice Using Plasmid DNA 2009 ·Cancer Research ·Stephen M. Wiesner,Stacy A. Decker,Jon D. Larson,Katya Ericson,Colleen L. Forster,Jose L. Gallardo,Chunmei Long,Zachary L. Demorest,(unknown),Walter C. Low,Karen S. SantaCruz,David A. Largaespada,John R. Ohlfest	119
18	Rituximab-Induced Changes in Hematolymphoid Tissues Found at Autopsy 2008 ·American Journal of Clinical Pathology ·Adina Cioc,(unknown),B. A. Peterson,(unknown),Colleen L. Forster,Stefan E. Pambuccian	22
19	Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L)breakdown → 2005 ·Journal of Neuroscience ·Martin Ramsden,Linda Kotilinek,Colleen L. Forster,Jennifer Paulson,Eileen McGowan,Karen S. SantaCruz,(unknown),Mei Yue,Jada Lewis,George A. Carlson,Michael Hutton,Karen H. Ashe	529
20	Interferon regulatory factor-1 immunoreactivity in neurons and inflammatory cells following ischemic stroke in rodents and humans 2002 ·Acta Neuropathologica ·(unknown),Colleen L. Forster,Koreaki Sugimoto,H. Brent Clark,Stefanie N. Vogel,M. Elizabeth Ross,Costantino Iadecola	26

About Colleen L. Forster

Colleen L. Forster is a scholar working on Neurology, Physiology and Oncology, having authored 56 papers that have together received 4.3k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (12 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Immunotherapy and Immune Responses (5 papers). The work is most often cited by research in Neurology (1.0k citations), Physiology (2.3k citations) and Cellular and Molecular Neuroscience (1.1k citations). Colleen L. Forster has collaborated with scholars based in United States, Canada and Sweden. Frequent co-authors include Karen H. Ashe, Costantino Iadecola, Karen S. SantaCruz, Linda Kotilinek, Jennifer Paulson, Eileen McGowan, Jada Lewis, Mei Yue, Michael A. Kuskowski and Christopher Janus. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact